Back to top

FOURTH AMENDMENT of the COLLABORATION AGREEMENT

Collaboration Agreement

FOURTH AMENDMENT of the COLLABORATION AGREEMENT 

 | Document Parties: IDM PHARMA, INC. | Innogenetics N.V. You are currently viewing:
This Collaboration Agreement involves

IDM PHARMA, INC. | Innogenetics N.V.

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: FOURTH AMENDMENT of the COLLABORATION AGREEMENT
Governing Law: California     Date: 11/15/2005
Industry: Biotechnology and Drugs     Sector: Healthcare

FOURTH AMENDMENT of the COLLABORATION AGREEMENT 

, Parties: idm pharma  inc. , innogenetics n.v.
50 of the Top 250 law firms use our Products every day
 

Exhibit 10.25

*** Text Omitted and Filed Separately
Pursuant to a Confidential Treatment Request
Under 17 C.F.R. §§ 200.80(b)(4)
and 240.24b-2

FOURTH AMENDMENT of the COLLABORATION AGREEMENT

This Fourth Amendment of the Collaboration Agreement is made this 28 th day of September 2005 (the “Fourth Amendment”) by and between IDM Pharma, Inc. (formerly Epimmune Inc. (hereinafter referred to as “Epimmune”)), having an office and a place of business at 5820 Nancy Ridge Drive, San Diego, California 92121 U.S.A (hereinafter referred to as “IDMI”), and Innogenetics N.V. , having an office and a place of business at Technologiepark 6, B-9052 Ghent, Belgium (hereinafter referred to as “INNX”) to amend the Collaboration Agreement dated July 9, 2001 between IDMI and INNX (the “Agreement”), as amended by a First Amendment of the Collaboration Agreement, dated October 16, 2002 (the “First Amendment”), a Second Amendment of the Collaboration Agreement, dated October 7, 2003 (the “Second Amendment”) and a Third Amendment of the Collaboration Agreement, dated March 16, 2004 (the “Third Amendment”).

WHEREAS :

 

Epimmune and Genencor International, Inc. (“GCOR”) executed the Agreement and proceeded to work thereunder;

 

 

 

 

Epimmune and GCOR executed the First Amendment and the Second Amendment;

 

 

 

 

GCOR assigned this Agreement, amended as aforesaid, to INNX by virtue of an Assignment and, in that capacity, INNX replaced GCOR as a signatory to the Agreement and continued to work with Epimmune thereunder;

 

 

 

 

Epimmune and INNX executed the Third Amendment;

 

 

 

 

Epimmune Inc. combined with IDM S.A. and changed its name to IDM Pharma, Inc.;

 

 

 

 

IDMI and INNX (hereinafter sometimes individually referred to as the “Party” and collectively as the “Parties”) have successfully collaborated under the Agreement and its various Amendments, as aforesaid; and

 

 

 

 

The Parties are desirous of extending the Agreement in scope and duration as specified herein under the following terms and conditions.

NOW THEREFORE, the Parties hereto agree to amend the Agreement, as follows:

1.

 

The Parties acknowledge that, as of the Effective Date of this Fourth Amendment, references to EPMN in the Agreement, as amended by the First Amendment, the Second Amendment, the Third Amendment and this Fourth Amendment, shall be amended so as to replace “EPMN” with “IDMI.”

 

 

 

2.

 

Section 4.1 shall be amended to read, as follows:

 

 

 

 

 

 

 

 

 

 

 

 

“4.1

 

(a) Funding . Subject to


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more